SCHEMBL3634715

SCHEMBL3634715

CC(C)(C)n1cc(NC(=O)Nc2ccc(Oc3cc(-c4nc[nH]n4)ncn3)cc2F)cn1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.49
FGFR1 P11362 1/20 0.49
BRAF P15056 11/20 0.47
MAPK14 Q16539 1/20 0.46
TNNI3K Q59H18 1/20 0.46
RAF1 P04049 2/20 0.43
FLT1 P17948 3/20 0.41
FLT4 P35916 2/20 0.41
AURKA O14965 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
PDGFRA P16234 1/20 0.39
TEK Q02763 1/20 0.39
PTK2 Q05397 1/20 0.39
FLT3 P36888 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064647 0.86 KDR (0.48) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL5064666 0.85 KDR (0.52) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL5067416 0.85 KDR (0.51) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL5064651 0.84 KDR (0.51) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL3665903 0.83 KDR (0.48) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL3666008 0.83 KDR (0.48) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL5064068 0.83 KDR (0.48) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL5067452 0.80 KDR (0.51) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL3798475 0.80 KDR (0.46) KDRFGFR1BRAFMAPK14TNNI3K
SCHEMBL3666384 0.79 KDR (0.47) KDRFGFR1BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146718-A1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES Deciphera Pharmaceuticals, LLC. (US) 2010-01-27 EP disclosed
WO-2008131253-A1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2008-10-30 WO disclosed